Global Veterinary Infectious Disease Diagnostics Market 2026: Overview, Share, Analysis, Growth & Research Report
iCrowdNewswire
Oct 06, 2021
According to the latest report by IMARC Group, titled “Veterinary Diagnostics Market Report: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the market to grow at a CAGR of 8.6% during 2021-2026.
Veterinary infectious disease diagnostic technologies comprise cytology, immunohistochemical stains, bacteriological culture, fecal examination, and nucleic acid amplification. They assist in detecting diseases, evaluating the overall health, and providing effective treatment to animals. As it also reduces the risk of cross-contamination, they are extensively utilized in reference laboratories, veterinary clinics, and research institutes and universities across the globe.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Global Veterinary Diagnostics Market Trends:
The increasing adoption of companion animals on account of inflating income levels and the rising trend of nuclear families represents one of the major factors strengthening the market growth. Besides this, there is a rise in the prevalence of zoonotic diseases among animals. This, along with the growing consumption of animal-derived products and rising concerns about food safety around the world, is driving the market. Furthermore, the coronavirus disease (COVID-19) outbreak is positively influencing the demand for polymerase chain reaction (PCR) testing to analyze the impact of the infection on animals, which is impelling the market growth.
Request Free Sample Report: https://www.imarcgroup.com/veterinary-diagnostics-market/requestsample
Global Veterinary Diagnostics Market 2021-2026 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
BioChek B.V., Biomérieux SA, Heska Corporation, IDEXX Laboratories Inc., IDvet, Neogen Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Virbac and Zoetis Inc.
The report has segmented the market on the basis on region, disc type, material type and end user.
Breakup by Product:
- Instruments
- Kits and Reagents
- Software and Services
Breakup by Technology:
- Immunodiagnostics
- Clinical Biochemistry
- Molecular Diagnostics
- Hematology
- Others
Breakup by Animal Type:
- Companion Animals
- Dogs
- Cats
- Others
- Livestock Animals
- Cattle
- Swine
- Poultry
- Others
Breakup by Disease Type:
- Infectious Diseases
- Non-infectious Diseases
- Hereditary, Congenital and Acquired Diseases
- General Ailments
- Structural and Functional Diseases
Breakup by End User:
- Reference Laboratories
- Veterinary Hospitals and Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/veterinary-diagnostics-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Related Report by IMARC Group:
Latin America Telehealth Market Report: https://www.imarcgroup.com/latin-america-telehealth-market
Premenstrual Syndrome Treatment Market Report: https://www.imarcgroup.com/premenstrual-syndrome-treatment-market
United States Transfection Technologies Market Report: https://www.imarcgroup.com/united-states-transfection-technologies-market
Latin America Generic Injectables Market Report: https://www.imarcgroup.com/latin-america-generic-injectables-market
India Generic Injectables Market Report: https://www.imarcgroup.com/india-generic-injectables-market
Europe Organ Preservation Market Report: https://www.imarcgroup.com/europe-organ-preservation-market
Europe CBD Oil Market Report: https://www.imarcgroup.com/europe-cbd-oil-market
India Organ Preservation Market Report: https://www.imarcgroup.com/india-organ-preservation-market
United States Insulin Pumps Market Report: https://www.imarcgroup.com/united-states-insulin-pumps-market
Recombinant DNA Technology Market Report: https://www.imarcgroup.com/recombinant-dna-technology-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Information:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800